NDRA Stock Analysis: Buy, Sell, or Hold?
NDRA - ENDRA Life Sciences Inc. Common Stock
$4.69
0.04 (0.86%)
▲
5d:
+2.18%
30d:
+28.85%
90d:
+3.53%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When NDRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NDRA is 9.6% above fair value ($4.28). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NDRA is 9.6% above fair value ($4.28). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NDRA is currently trading at $4.69, which is considered extended relative to its 30-day fair value range of $3.29 to $4.28.
Technical Outlook: Technically, NDRA is in a strong downtrend. Immediate support is located at $3.19, while resistance sits at $4.98.
Market Sentiment: NDRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+539.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NDRA is in a strong downtrend. Immediate support is located at $3.19, while resistance sits at $4.98.
Market Sentiment: NDRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+539.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$3.29 -
$4.28
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+9.6% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 539.7% below Wall St target ($30.00)
Fair Price Analysis
30-Day Fair Range
$3.29 -
$4.28
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.19
Resistance Level
$4.98
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Wall Street Target
$30.00
(+539.7%)
Share & Embed Analysis
Last updated: April 05, 2026 1:46 PM ET
Data refreshes hourly during market hours. Next update: 2:46 PM
Data refreshes hourly during market hours. Next update: 2:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NDRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 67 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 62 BUY |
